UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 192,964 Shares of Ralliant Corporation $RAL

Key Points

• UBS Asset Management cut its Ralliant stake by 39.1%, selling 192,964 shares and retaining 299,980 shares worth approximately $22.1 million. Other institutional investors, including BlackRock and Flossbach von Storch, established or expanded significant positions.
• Ralliant reported quarterly EPS of $0.68, beating estimates of $0.63, on revenue of $567.8 million. The company issued fiscal 2026 EPS guidance of $2.76–$2.90 and expects third-quarter EPS of $0.72–$0.78.
• The stock was recently trading at $63.46, while analysts maintained a consensus “Moderate Buy” rating with an average price target of $75.70. Ralliant also declared a quarterly dividend of $0.05 per share, implying a 0.3% annual yield.

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its holdings in shares of Ralliant Corporation (NYSE:RAL - Free Report) by 39.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 299,980 shares of the company's stock after selling 192,964 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.27% of Ralliant worth $22,088,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of RAL. BlackRock Inc. acquired a new stake in shares of Ralliant during the second quarter valued at about $1,039,481,000. Irenic Capital Management LP grew its holdings in shares of Ralliant by 424.1% during the first quarter. Irenic Capital Management LP now owns 1,740,218 shares of the company's stock worth $72,376,000 after purchasing an additional 1,408,176 shares during the last quarter. Rokos Capital Management LLP acquired a new position in shares of Ralliant in the first quarter valued at approximately $42,022,000. Flossbach Von Storch SE acquired a new position in shares of Ralliant in the second quarter valued at approximately $222,460,000. Finally, Sei Investments Co. raised its holdings in Ralliant by 193.7% in the 1st quarter. Sei Investments Co. now owns 182,342 shares of the company's stock valued at $7,583,000 after buying an additional 120,248 shares during the last quarter.

Ralliant Stock Up 1.1%

Ralliant stock opened at $63.46 on Friday. The firm has a market cap of $7.02 billion, a price-to-earnings ratio of -5.85, a PEG ratio of 2.33 and a beta of 1.54. Ralliant Corporation has a 52-week low of $37.27 and a 52-week high of $75.41. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. The firm has a 50 day moving average price of $67.52 and a two-hundred day moving average price of $57.10.

Ralliant (NYSE:RAL - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.68 EPS for the quarter, beating analysts' consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The company had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Equities analysts predict that Ralliant Corporation will post 2.87 EPS for the current year.

Ralliant Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant's dividend payout ratio is -1.84%.

Insiders Place Their Bets

In other news, SVP Karen M. Bick sold 6,062 shares of the business's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the transaction, the senior vice president directly owned 31,668 shares of the company's stock, valued at $2,280,096. The trade was a 16.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the company's stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer owned 251,967 shares in the company, valued at approximately $18,088,710.93. The trade was a 4.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.42% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently commented on RAL. Oppenheimer lifted their target price on shares of Ralliant from $50.00 to $65.00 and gave the stock an "outperform" rating in a research report on Wednesday, May 13th. Truist Financial reaffirmed a "buy" rating and set a $82.00 price target (up from $68.00) on shares of Ralliant in a research note on Friday, July 31st. BMO Capital Markets started coverage on shares of Ralliant in a report on Monday, July 20th. They set a "market perform" rating and a $78.00 price target on the stock. Royal Bank Of Canada boosted their price objective on shares of Ralliant from $71.00 to $73.00 and gave the stock a "sector perform" rating in a research note on Friday, July 31st. Finally, Wall Street Zen lowered Ralliant from a "strong-buy" rating to a "buy" rating in a research report on Sunday, August 30th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $75.70.

Ralliant Company Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source